Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies
Phase 1
54
about 7.1 years
18+
1 site in IL
About this study
Researchers are testing the safety of a treatment combining irinotecan with 5-FU, leucovorin/folinic acid, oxaliplatin, and docetaxel. The trial will involve adults who have adenocarcinoma, gastroesophageal junction adenocarcinoma, or pancreatic adenocarcinoma.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take 5-Fluorouracil
- 2.Take Docetaxel
- 3.Take Irinotecan
- +2 more
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
fluorouracil (Antimetabolite; mimics uracil to disrupt DNA/RNA in cancer cells), docetaxel, irinotecan, Antidotes, Deterrents, and Toxicologic Agents (Enzyme Interactions), oxaliplatin
infusion, injection (Injection)
Secondary: Overall Response Rate, Overall survival rate, Progression free survival rate